These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3818107)
1. Penetration of ciprofloxacin into human lung tissue following intravenous injection. Schlenkhoff D; Dalhoff A; Knopf J; Opferkuch W Infection; 1986; 14(6):299-300. PubMed ID: 3818107 [No Abstract] [Full Text] [Related]
2. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients. Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681 [TBL] [Abstract][Full Text] [Related]
3. Tissue penetration and metabolism of ciprofloxacin. Wise R; Donovan IA Am J Med; 1987 Apr; 82(4A):103-7. PubMed ID: 3578319 [TBL] [Abstract][Full Text] [Related]
4. Penetration of ciprofloxacin into gynecologic tissues. Dalhoff A; Weuta H Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027 [TBL] [Abstract][Full Text] [Related]
5. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues. Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996 [TBL] [Abstract][Full Text] [Related]
6. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing. Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527 [No Abstract] [Full Text] [Related]
7. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin. Rohwedder R; Bergan T; Caruso E; Thorsteinsson SB; Della Torre H; Scholl H Chemotherapy; 1991; 37(4):229-38. PubMed ID: 1790720 [TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose. Birmingham MC; Guarino R; Heller A; Wilton JH; Shah A; Hejmanowski L; Nix DE; Schentag JJ J Antimicrob Chemother; 1999 Mar; 43 Suppl A():43-8. PubMed ID: 10225571 [TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients. Haraguchi S; Hioki M; Yamashita K; Orii K; Yamashita Y; Kawamura J; Takushima M; Endo N; Koizumi K; Shimizu K Surg Today; 2007; 37(4):282-4. PubMed ID: 17387558 [TBL] [Abstract][Full Text] [Related]
10. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration. Goormans E; Dalhoff A; Kazzaz B; Branolte J Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582 [TBL] [Abstract][Full Text] [Related]
11. The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration. Dan M; Torossian K; Weissberg D; Kitzes R Eur J Clin Pharmacol; 1993; 44(1):101-2. PubMed ID: 8436147 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats. Siefert HM; Maruhn D; Scholl H Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707 [TBL] [Abstract][Full Text] [Related]
13. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis. Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351 [TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases. Fraschini F; Braga PC; Cosentina R; Salvini P; Cortelazzi R; Scarpazza G; Scaglione F; Trazzi R; Odero A Int J Clin Pharmacol Res; 1987; 7(1):63-71. PubMed ID: 3583489 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. Siefert HM; Maruhn D; Maul W; Förster D; Ritter W Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetic disposition of fluoroquinolones in the lung. Wise R; Baldwin DR; Andrews JM; Honeybourne D J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831 [TBL] [Abstract][Full Text] [Related]
17. Comparative scintigraphic study of 99mTc ciprofloxacin pharmacokinetics after intravenous and lymphotropic administration in experimental pulmonary suppuration. Lishmanov YB; Sazonova SI; Sokolovich EG; Chernov VI Bull Exp Biol Med; 2005 Jan; 139(1):94-7. PubMed ID: 16142288 [TBL] [Abstract][Full Text] [Related]
18. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy. Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627 [TBL] [Abstract][Full Text] [Related]
19. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin. Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587 [TBL] [Abstract][Full Text] [Related]
20. Penetration activities of ciprofloxacin into muscle, skin and fat following oral administration. Aigner KR; Dalhoff A J Antimicrob Chemother; 1986 Nov; 18(5):644-5. PubMed ID: 3804886 [No Abstract] [Full Text] [Related] [Next] [New Search]